Litcius/Paper detail

Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker

Amit Ghati, Paulami Dam, Didar Tasdemir, Ahmet Katı, H. Sellami, Gülten Can Sezgin, Nilay Ildız, Octávio Luiz Franco, Amit Kumar Mandal, İsmail Öçsoy

2020Current Opinion in Colloid & Interface Science59 citationsDOIOpen Access PDF

Topics & Concepts

Respiratory systemCollectinPulmonary surfactantImmunologyLungMedicineRespiratory distressCoronavirusRespiratory diseaseDiffuse alveolar damagePathologyDiseaseBiologyInternal medicineImmune systemAcute respiratory distressCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)AnesthesiaBiochemistryInnate immune systemNeonatal Respiratory Health ResearchRespiratory Support and MechanismsRespiratory viral infections research
Exogenous pulmonary surfactant: A review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker | Litcius